John J. Winge - Jan 5, 2023 Form 4 Insider Report for SeaSpine Holdings Corp (SPNE)

Signature
/s/Paul Benny, Attorney-in-Fact for John J. Winge
Stock symbol
SPNE
Transactions as of
Jan 5, 2023
Transactions value $
$0
Form type
4
Date filed
1/9/2023, 06:18 PM
Previous filing
Jan 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPNE Common Stock Disposed to Issuer -91K -100% 0 Jan 5, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SPNE Restricted Stock Units Disposed to Issuer -14.4K -100% 0 Jan 5, 2023 Common Stock 14.4K $0.00 Direct F2, F3, F4
transaction SPNE Restricted Stock Units Disposed to Issuer -30.2K -100% 0 Jan 5, 2023 Common Stock 30.2K Direct F2, F5, F6
transaction SPNE Employee Stock Option (Right to Buy) Disposed to Issuer -40K -100% 0 Jan 5, 2023 Common Stock 40K $15.68 Direct F7, F8
transaction SPNE Employee Stock Option (Right to Buy) Disposed to Issuer -59.6K -100% 0 Jan 5, 2023 Common Stock 59.6K $14.19 Direct F9, F10
transaction SPNE Employee Stock Option (Right to Buy) Disposed to Issuer -31.1K -100% 0 Jan 5, 2023 Common Stock 31.1K $18.24 Direct F11, F12
transaction SPNE Employee Stock Option (Right to Buy) Disposed to Issuer -48.7K -100% 0 Jan 5, 2023 Common Stock 48.7K $12.01 Direct F13, F14
transaction SPNE Employee Stock Option (Right to Buy) Disposed to Issuer -5.34K -100% 0 Jan 5, 2023 Common Stock 5.34K $9.93 Direct F15, F16
transaction SPNE Employee Stock Option (Right to Buy) Disposed to Issuer -18.9K -100% 0 Jan 5, 2023 Common Stock 18.9K $15.00 Direct F17, F18
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

John J. Winge is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 37,862 Orthofix Medical Inc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger.
F2 Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock.
F3 The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024.
F4 These restricted stock units were assumed by Orthofix in the merger and replaced by 6,008 Orthofix restricted stock units.
F5 The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025.
F6 These restricted stock units were assumed by Orthofix in the merger and replaced by 12,592 Orthofix restricted stock units.
F7 The option vests as to 25% of the underlying shares on May 1, 2016 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F8 This option was assumed by Orthofix in the merger and replaced with an option to purchase 16,652 shares of Orthofix at a price of $37.67 per share.
F9 The option vests in sixteen substantially equal quarterly installments beginning on March 31, 2016.
F10 This option was assumed by Orthofix in the merger and replaced with an option to purchase 24,795 shares of Orthofix at a price of $34.09 per share.
F11 The option vests as to 25% of the underlying shares on January 1, 2020 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F12 This option was assumed by Orthofix in the merger and replaced with an option to purchase 12,954 shares of Orthofix at a price of $43.82 per share.
F13 The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F14 This option was assumed by Orthofix in the merger and replaced with an option to purchase 20,264 shares of Orthofix at a price of $28.85 per share.
F15 The option fully vested and became exercisable on June 21, 2020.
F16 This option was assumed by Orthofix in the merger and replaced with an option to purchase 2,223 shares of Orthofix at a price of $23.86 per share.
F17 The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F18 This option was assumed by Orthofix in the merger and replaced with an option to purchase 7,873 shares of Orthofix at a price of $36.04 per share.